Amgen Inc
(HKSE:04332)
HK$
1761
0 (0%)
Market Cap: 1.17 Til
Enterprise Value: 1.57 Til
PE Ratio: 35.86
PB Ratio: 20.00
GF Score: 92/100 Amgen Inc at Bank of America Healthcare Conference Transcript
May 11, 2022 / 04:20PM GMT
Release Date Price:
HK$1850
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Welcome to the second day of the Bank of America Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here. And we are thrilled to have with us on stage, Amgen. And speaking on behalf of Amgen, we have Peter Griffith, CFO; and Rob Lenz, Senior Vice President, Global Development. Welcome, guys.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
Great to be here.
Rob Lenz
Amgen Inc. - SVP of Global Development
Great to be here.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
Thank you so much to Bank of America, BofA, for inviting us.
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Great to do the meeting in person, too, right?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot